Nico Van Zandwijk, MD, PhD | Authors

The Role of Prognostic Factors and Oncogenes in the Detection and Management of Non-Small-Cell Lung Cancer

January 02, 1998

Like other epithelial tumors, non-small-cell lung cancer (NSCLC) is a result of a series of genetic and epigenetic changes that eventually progress to invasive cancer. The order and timing of these changes, involving specific

Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced Non-Small-Cell Lung Cancer

April 01, 1997

A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative